-
Clinical Updates
Jul 24, 13 FDA ApprovalsBelgian pharmaceutical group UCB SA said a committee of the U.S. Food and Drug Administration voted in favor of… »
Jul 24, 13 Clinical UpdatesRoche’s experimental leukaemia drug known as GA101 delayed disease progression in people with one of the most common forms of… »
Jul 18, 13 Clinical UpdatesA drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of the… »
Jul 17, 13 FDA ApprovalsU.S. health regulators need more time to review Merck & Co’s application to sell sugammadex, an injection designed to reverse… »
Jul 15, 13 FDA ApprovalsThe U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are… »
Jul 12, 13 Clinical UpdatesAlnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein… »
Jul 12, 13 Drug NewsCelgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in newly… »
Jul 05, 13 FDA ApprovalsSwiss drugmaker Novartis’ eye drug Lucentis has been approved as a treatment for a further condition related to worsening eyesight… »
Jul 02, 13 Clinical UpdatesInsmed Inc’s experimental lung infection drug fared no better than a competing drug developed by Novartis AG in a lung… »
Jul 02, 13 FDA ApprovalsMerck & Co Inc said the U.S. Food and Drug Administration rejected the company’s experimental insomnia drug, citing safety issues.
… »
Jun 28, 13 FDA ApprovalsPatients with a form of the chronic blood disorder hemophilia will soon have a new therapy that not only treats… »
Jun 28, 13 Clinical UpdatesEuropean regulators have recommended approval of a drug from Raptor Pharmaceutical to treat a rare genetic disorder that can cause… »
Jun 28, 13 FDA ApprovalsFrench drugmaker Sanofi said it won approval from the Japanese government for its Lyxumia drug for the treatment of Type… »
Jun 27, 13 Clinical UpdatesNew research suggests that the rapid rise of antibiotic resistance correlates with oral ingestion of antibiotics, raising the possibility that… »
Jun 24, 13 FDA ApprovalsThe U.S. Food and Drug Administration approved Theravance Inc’s antibiotic lung drug to treat a type of bacterial pneumonia affecting… »
Subscribe to the "News" RSS Feed 
TOP ۞
